REQUEST A DEMO
Total
USD $0.00
Search more companies

Innovative Pharmaceutical Biotech Limited (Hong Kong SAR, China)

Main Activities: Pharmaceutical and Medicine Manufacturing
Full name: Innovative Pharmaceutical Biotech Limited Profile Updated: September 24, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2024 Available in: English & Chinese Download a sample report

Innovative Pharmaceutical Biotech Limited ("IPB") is a company located in Hong Kong. It was formerly known as United Gene High-Tech Group Limited and was involved in genetic testing, healthcare management, and the distribution of bio-industrial products. IPB currently operates in two main segments: research and development of pharmaceutical products, and trading of beauty equipment and products. The company is currently focused on developing an orally administered insulin product and aims to expand its research and development segment by acquiring additional pharmaceutical products with commercial viability. IPB's shares are listed on the Main Board of the Hong Kong Stock Exchange under the code 399.

Headquarters
Unit No. 2111, 21st Floor, West Tower Shun Tak Centre, Nos. 168-200 Connaught Road, Central, Hong Kong
Hong Kong; Hong Kong;

Contact Details: Purchase the Innovative Pharmaceutical Biotech Limited report to view the information.

Website: http://www.ipb.asia

Basic Information
Total Employees:
Purchase the Innovative Pharmaceutical Biotech Limited report to view the information.
Outstanding Shares:
Purchase the Innovative Pharmaceutical Biotech Limited report to view the information.
Registered Capital:
Purchase the Innovative Pharmaceutical Biotech Limited report to view the information.
Financial Auditors:
Purchase the Innovative Pharmaceutical Biotech Limited report to view the information.
Incorporation Date:
May 24, 2000
Key Executives
Purchase this report to view the information.
Chairman
Purchase this report to view the information.
Director/Member of the Board
Purchase this report to view the information.
Director/Member of the Board
Purchase this report to view the information.
Director/Member of the Board
Purchase this report to view the information.
Director/Member of the Board
Ownership Details
Purchase this report to view the information.
60.77%
Purchase this report to view the information.
24.87%
Purchase this report to view the information.
0.45%
Purchase this report to view the information.
Purchase this report to view the information.
Subsidiaries
Able Earn Investment Limited
100%
China United Gene Health Limited
100%
Clear Rich International Limited
100%
Company Performance
Financial values in the chart are available after Innovative Pharmaceutical Biotech Limited report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency HKD. Absolute financial data is included in the purchased report.
Net sales revenue
-18.35%
Total operating revenue
-18.34%
Operating profit (EBIT)
N/A
EBITDA
33.28%
Net Profit (Loss) for the Period
N/A
Total assets
-0.07%
Total equity
127.25%
Operating Profit Margin (ROS)
N/A
Net Profit Margin
N/A
Return on Equity (ROE)
N/A
Debt to Equity Ratio
-492.94%
Quick Ratio
0.02%
Cash Ratio
0.01%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?